373 related articles for article (PubMed ID: 23942785)
41. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
[TBL] [Abstract][Full Text] [Related]
42. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
43. Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma.
Şumnu Ş; Mehtap Ö; Mersin S; Toptaş T; Görür G; Gedük A; Ünal S; Polat MG; Aygün K; Yenihayat EM; Albayrak H; Uluköylü Mengüç M; Tarkun P; Hacıhanifioğlu A
Int J Lab Hematol; 2021 Aug; 43(4):638-644. PubMed ID: 33904653
[TBL] [Abstract][Full Text] [Related]
44. [Possibility of formation of the S100A8/A9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles].
Ishihara K; Namura T; Murayama H; Arai S; Totani M; Ikemoto M
Rinsho Byori; 2009 Apr; 57(4):324-31. PubMed ID: 19489433
[TBL] [Abstract][Full Text] [Related]
45. The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.
Aljaberi N; Tronconi E; Schulert G; Grom AA; Lovell DJ; Huggins JL; Henrickson M; Brunner HI
Pediatr Rheumatol Online J; 2020 Jan; 18(1):7. PubMed ID: 31948488
[TBL] [Abstract][Full Text] [Related]
46. Macrophage migration inhibitory factor in systemic lupus erythematosus.
Foote A; Briganti EM; Kipen Y; Santos L; Leech M; Morand EF
J Rheumatol; 2004 Feb; 31(2):268-73. PubMed ID: 14760795
[TBL] [Abstract][Full Text] [Related]
47. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
48. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA
Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988
[TBL] [Abstract][Full Text] [Related]
49. Analysis of plasma levels and polymorphisms of S100A8/9 and S100A12 in patients with acute pancreatitis.
Farkas G; Tiszlavicz Z; Takács T; Szabolcs A; Farkas G; Somogyvári F; Mándi Y
Pancreas; 2014 Apr; 43(3):485-7. PubMed ID: 24622086
[No Abstract] [Full Text] [Related]
50. S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study.
Ludwig S; Stephan C; Lein M; Loening SA; Jung K
Prostate; 2007 Sep; 67(12):1301-7. PubMed ID: 17626245
[TBL] [Abstract][Full Text] [Related]
51. A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?
Yu Y; Shi H; Wang Y; Yu Y; Chen R
ESC Heart Fail; 2024 Feb; 11(1):503-512. PubMed ID: 38083998
[TBL] [Abstract][Full Text] [Related]
52. Macro- and microvascular function in habitually exercising systemic lupus erythematosus patients.
Barnes JN; Nualnim N; Dhindsa M; Renzi CP; Tanaka H
Scand J Rheumatol; 2014; 43(3):209-16. PubMed ID: 24392783
[TBL] [Abstract][Full Text] [Related]
53. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study.
Aghdassi E; Ma DW; Morrison S; Hillyer LM; Clarke S; Gladman DD; Urowitz MB; Fortin PR
JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):198-208. PubMed ID: 21378249
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.
Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM
BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528
[TBL] [Abstract][Full Text] [Related]
55. Secretion of S100A8, S100A9, and S100A12 by Neutrophils Involves Reactive Oxygen Species and Potassium Efflux.
Tardif MR; Chapeton-Montes JA; Posvandzic A; Pagé N; Gilbert C; Tessier PA
J Immunol Res; 2015; 2015():296149. PubMed ID: 27057553
[TBL] [Abstract][Full Text] [Related]
56. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
57. A case with transient increases in serum S100A8/A9 levels implying acute inflammatory responses after pancreatic islet transplantation.
Ikemoto M; Matsumoto S; Egawa H; Okitsu T; Iwanaga Y; Umemoto S; Itoh H; Murayama H; Fujita M
Ann Clin Biochem; 2007 Nov; 44(Pt 6):570-2. PubMed ID: 17961315
[TBL] [Abstract][Full Text] [Related]
58. The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis.
Bai X; Xu PC; Chen T; Zhang HM; Wu SJ; Yang X; Gao S; Jia JY; Jiang JQ; Yan TK
BMC Immunol; 2022 Sep; 23(1):42. PubMed ID: 36088289
[TBL] [Abstract][Full Text] [Related]
59. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
[TBL] [Abstract][Full Text] [Related]
60. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.
Schiopu A; Cotoi OS
Mediators Inflamm; 2013; 2013():828354. PubMed ID: 24453429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
